MAGELLAN HEALTH INC's ticker is MGLN and the CUSIP is 559079207. A total of 186 filers reported holding MAGELLAN HEALTH INC in Q2 2013. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $302,000 | +0.3% | 3,184 | 0.0% | 0.00% | – |
| Q3 2021 | $301,000 | -39.3% | 3,184 | -39.5% | 0.00% | – |
| Q2 2021 | $496,000 | -73.1% | 5,265 | -73.4% | 0.00% | – |
| Q1 2021 | $1,843,000 | +305.1% | 19,769 | +217.4% | 0.00% | – |
| Q2 2020 | $455,000 | -2.2% | 6,229 | -35.6% | 0.00% | – |
| Q1 2020 | $465,000 | -61.4% | 9,670 | -37.2% | 0.00% | – |
| Q4 2019 | $1,206,000 | +89.0% | 15,405 | +49.9% | 0.00% | – |
| Q3 2019 | $638,000 | -37.8% | 10,278 | -3.7% | 0.00% | – |
| Q2 2018 | $1,025,000 | -25.1% | 10,678 | -16.4% | 0.00% | – |
| Q1 2018 | $1,369,000 | +10.9% | 12,778 | 0.0% | 0.00% | – |
| Q4 2017 | $1,234,000 | +11.9% | 12,778 | 0.0% | 0.00% | – |
| Q3 2017 | $1,103,000 | +2.0% | 12,778 | -13.8% | 0.00% | – |
| Q2 2017 | $1,081,000 | -50.0% | 14,831 | -52.7% | 0.00% | -100.0% |
| Q1 2017 | $2,163,000 | -52.0% | 31,326 | -47.7% | 0.00% | 0.0% |
| Q4 2016 | $4,506,000 | -1.4% | 59,871 | -29.7% | 0.00% | 0.0% |
| Q3 2016 | $4,572,000 | -12.8% | 85,115 | +6.8% | 0.00% | 0.0% |
| Q2 2016 | $5,243,000 | +19.9% | 79,725 | +23.9% | 0.00% | 0.0% |
| Q1 2016 | $4,373,000 | +151.0% | 64,366 | +127.9% | 0.00% | – |
| Q4 2015 | $1,742,000 | -37.4% | 28,245 | -43.7% | 0.00% | -100.0% |
| Q3 2015 | $2,781,000 | -20.4% | 50,176 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $3,492,000 | -19.7% | 49,840 | -18.8% | 0.00% | 0.0% |
| Q1 2015 | $4,346,000 | +45.2% | 61,361 | +23.0% | 0.00% | 0.0% |
| Q4 2014 | $2,993,000 | +9.2% | 49,868 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $2,742,000 | -18.3% | 50,110 | -7.1% | 0.00% | 0.0% |
| Q2 2014 | $3,355,000 | -11.5% | 53,911 | -15.6% | 0.00% | 0.0% |
| Q1 2014 | $3,791,000 | -13.2% | 63,872 | -12.4% | 0.00% | 0.0% |
| Q4 2013 | $4,367,000 | -56.0% | 72,898 | -56.0% | 0.00% | -66.7% |
| Q3 2013 | $9,924,000 | +604.3% | 165,521 | +558.9% | 0.00% | – |
| Q2 2013 | $1,409,000 | – | 25,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altalis Capital Management LLC | 130,506 | $11,262,000 | 7.39% |
| Hudson Executive Capital LP | 197,400 | $17,036,000 | 4.28% |
| Hood River Capital Management LLC | 507,355 | $43,785,000 | 2.78% |
| Hillcrest Asset Management LLC | 102,230 | $8,822,000 | 1.60% |
| Dean Capital Management | 38,719 | $3,341,000 | 1.56% |
| Smith, Graham & Co., Investment Advisors, LP | 151,061 | $13,037,000 | 1.37% |
| DEAN INVESTMENT ASSOCIATES, LLC | 56,950 | $4,915,000 | 0.75% |
| Orbimed Advisors | 882,600 | $76,168,000 | 0.73% |
| Aviance Capital Partners, LLC | 22,200 | $1,916,000 | 0.65% |
| Alambic Investment Management, L.P. | 63,413 | $5,473,000 | 0.60% |